| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.12B | 117.53B | 103.07B | 95.86B | 90.42B | 84.43B |
| Gross Profit | 20.51B | 21.84B | 19.14B | 17.70B | 15.67B | 14.69B |
| EBITDA | 4.47B | 5.47B | 4.04B | 3.78B | 3.15B | 3.34B |
| Net Income | 2.74B | 3.63B | 2.44B | 2.07B | 960.00M | 1.43B |
Balance Sheet | ||||||
| Total Assets | 96.36B | 101.53B | 94.45B | 95.52B | 86.81B | 86.46B |
| Cash, Cash Equivalents and Short-Term Investments | 8.45B | 9.03B | 8.45B | 8.87B | 7.53B | 6.92B |
| Total Debt | 15.83B | 11.56B | 17.77B | 18.96B | 21.38B | 21.73B |
| Total Liabilities | 46.22B | 44.56B | 46.87B | 48.36B | 45.19B | 46.17B |
| Stockholders Equity | 49.95B | 56.77B | 47.38B | 47.01B | 41.49B | 40.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.32B | 2.36B | 4.63B | 2.41B | -330.00M |
| Operating Cash Flow | 0.00 | 8.56B | 4.24B | 5.60B | 3.66B | 1.09B |
| Investing Cash Flow | 0.00 | -660.00M | -1.48B | -869.00M | -1.45B | -2.09B |
| Financing Cash Flow | 0.00 | -7.42B | -3.20B | -3.81B | -1.54B | 993.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥343.09B | 7.92 | 11.34% | 3.38% | 2.99% | 0.84% | |
75 Outperform | ¥42.18B | 16.04 | ― | 1.90% | 14.03% | 48.65% | |
73 Outperform | ¥102.74B | 5.86 | ― | 3.74% | -3.93% | 3.02% | |
73 Outperform | ¥362.83B | 9.25 | ― | 3.13% | 1.46% | 24.34% | |
69 Neutral | ¥444.26B | 14.68 | ― | 3.37% | 5.27% | -24.70% | |
68 Neutral | ¥103.33B | 9.91 | ― | 2.91% | 32.91% | 61.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |